Overview
This webinar features two presentations followed by a question and answer session. Faculty will present a summary of key radiotherapy presentations from IASLC’s 2019 World Conference on Lung Cancer (WCLC) and 2019 American Society of Thoracic Radiation Oncology (ASTRO) annual meeting. The presentations will include Phase II and III clinical trials, advanced technologies (e.g. proton therapy) and clinical use of combination radiation and drug treatment.
This webinar is designed to meet the educational needs of radiation oncologists, clinical oncologists, medical physicists, therapy radiographers, advanced practice nurses, physician’s assistants and other healthcare professionals who diagnose and treat patients with lung cancer.
At the conclusion of this activity, the learner will be able to:
- Discuss practice changing studies.
- Identify advances in radiation technology.
Daly ME, Monjazeb AM, Kelly K. Clinical Trials Integrating Immunotherapy and Radiation for Non–Small-Cell Lung Cancer. J Thorac Onc. 2015;10(12):1685-1693.
Moderator:
- Prof. Corinne Faivre-Finn, FRCR MD PhD
- Professor of Thoracic Radiation Oncology
- University of Manchester
- Consultant Clinical Oncologist,
- The Christie NHS Foundation Trust
- Disclosure: No relevant financial relationships.
Radiotherapy Highlights from WCLC 2019
- Laurie E. Gaspar MD MBA FACR FASTRO
- Professor Emerita,
- Department of Radiation Oncology
- University of Colorado
- Radiation Oncologist, Banner MD Anderson in Northern Colorado
- Disclosure: No relevant financial relationships.
Radiotherapy Highlights from ASTRO 2019
Andreas Rimner, MD
Associate Attending
Director of Thoracic Radiation Oncology Research, Department of Radiation Oncology
Memorial Sloan Kettering Cancer Center New York
Disclosure: Varian Medical Systems (contracted support/research grant, advisory board); Boehringer Ingelheim (contracted support/research grant), Pfizer (contracted support/research grant), AstraZeneca (contracted support/research grant, advisory board), Merck (contracted support/research grant, advisory board), Cybrexa (advisory Board), MoreHealth (consultant), Research to Practice (honorarium) and Philips/Elekta (travel support).
For any inquiries, please contact meetings@iaslc.org.
This webinar is designed to meet the educational needs of radiation oncologists, clinical oncologists, medical physicists, therapy radiographers, advanced practice nurses, physician’s assistants and other healthcare professionals who diagnose and treat patients with lung cancer.
At the conclusion of this activity, the learner will be able to:
- Discuss practice changing studies.
- Identify advances in radiation technology.
Daly ME, Monjazeb AM, Kelly K. Clinical Trials Integrating Immunotherapy and Radiation for Non–Small-Cell Lung Cancer. J Thorac Onc. 2015;10(12):1685-1693.
Moderator:
- Prof. Corinne Faivre-Finn, FRCR MD PhD
- Professor of Thoracic Radiation Oncology
- University of Manchester
- Consultant Clinical Oncologist,
- The Christie NHS Foundation Trust
- Disclosure: No relevant financial relationships.
Radiotherapy Highlights from WCLC 2019
- Laurie E. Gaspar MD MBA FACR FASTRO
- Professor Emerita,
- Department of Radiation Oncology
- University of Colorado
- Radiation Oncologist, Banner MD Anderson in Northern Colorado
- Disclosure: No relevant financial relationships.
Radiotherapy Highlights from ASTRO 2019
Andreas Rimner, MD
Associate Attending
Director of Thoracic Radiation Oncology Research, Department of Radiation Oncology
Memorial Sloan Kettering Cancer Center New York
Disclosure: Varian Medical Systems (contracted support/research grant, advisory board); Boehringer Ingelheim (contracted support/research grant), Pfizer (contracted support/research grant), AstraZeneca (contracted support/research grant, advisory board), Merck (contracted support/research grant, advisory board), Cybrexa (advisory Board), MoreHealth (consultant), Research to Practice (honorarium) and Philips/Elekta (travel support).
For any inquiries, please contact meetings@iaslc.org.